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INTRODUCTION
Although mechanical ventilation has remarkably improved
the outcome of premature infants, its detrimental effect, lung
injury from barotrauma and volutrauma has brought about
a problem of chronic lung disease of prematurity. Even if sur-
factant therapy can reduce lung injury from mechanical ven-
tilation, it has failed in some cases due to its uneven distribu-
tion, delayed action, and inactivation. Recently, newer mech-
anical ventilation modes and strategies aimed at reducing baro-
trauma and volutrauma have been introduced, but the risk of
lung injury from mechanical ventilation still remains. 
Several studies suggest newer technologies, such as partial
liquid ventilation (PLV) and high-frequency oscillatory ventila-
tion (HFOV) that can reduce the severity of lung injury in ex-
perimental and clinical settings (1-9). HFOV has been known
to be effective rescue modality in patients with a significant
impairment of gas exchange (10-12). In a prospective, random-
ized study of pediatric patients with respiratory failure, HFOV
was associated with a significant decrease in the incidence of
chronic lung disease in those patients who ultimately survived
(13). PLV evenly reduces surface tension of alveoli and enhances
alveolar recruitment, and improves gas exchange and pulmo-
nary function with minimizing lung injury (14-17). Combina-
tion of these two ventilatory strategies may have theoretical
advantages of further improvement of alveolar recruitments
and resultant enhanced gas exchange in severe respiratory fail-
ure with atelectasis-prone lung.
We accomplished this pilot study to evaluate whether the
combination of PLV by perfluorocarbon with HFOV can show
additive effects on the improvement of gas exchange without
detrimental effects on hemodynamic parameters in newborn
piglets with saline lavage-induced severe respiratory failure.
MATERIALS AND METHODS
Animal Preparations and Surgical Procedures
The institutional Animal Care and Use Committee of the
Samsung Biomedical Research Center, Seoul, Korea approved
this investigation.
Studies were performed on seven, 7-9 day-old newborn pig-
lets of mixed strain (Yorkshire, conventional breed, purchased
Chang Won Choi, Sun Young Koh*,
Yun Sil Chang, Won Soon Park
Department of Pediatrics, Samsung Medical Center, Jeil
Hospital*, Sungkyunkwan University School of Medicine,
Seoul, Korea
Address for correspondence
Won Soon Park, M.D.
Department of Pediatrics, Samsung Medical Center,
50 Ilwon-dong, Kangnam-gu, Seoul 135-710, Korea
Tel : +82.2-3410-3523, Fax : +82.2-3410-0043
E-mail : wspark@smc.samsung.co.kr
*This work was supported by Korea Research Founda-
tion Grant. (KRF-2001- 041-F00159)
663
J Korean Med Sci 2003; 18: 663-8
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Effects of Perfluorocarbon Associated High Frequency Oscillatory
Ventilation on Hemodynamics and Gas Exchange in the Newborn
Piglets with Respiratory Distress
We sought to know whether there is a further improvement in gas exchange when
partial liquid ventilation (PLV) is added to high-frequency oscillatory ventilation
(HFOV) in a piglet model of saline lavage-induced acute lung injury. Seven 7-9
day-old newborn piglets of mixed strain were treated with repeated saline lavage
to achieve a uniform degree of acute lung injury. Then, HFOV were applied to the
subject. Four animals received two consecutive doses (15 mL/kg) of perfluorode-
calin at 30-min interval (PFC+HFOV group). The other three animals remained on
HFOV alone (HFOV-only group). Repetitive lung lavage led to a significant acute
aggravation in both gas exchange and hemodynamic parameters. Subsequent
application of HFOV produced a significant rapid recovery in both gas exchange
and hemodynamic parameters to near baseline levels. During and after perfluo-
rodecalin dosing, there were no significant changes in gas exchange or hemody-
namic parameters over time in both groups, and no significant differences in gas
exchange or hemodynamic parameters between groups. We concluded that the
addition of 30 mL/kg of perfluorodecalin to HFOV showed no detrimental effect on
hemodynamics, but did not produce a significant improvement in gas exchange
over a three-hour period.
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from Paju farm, Paju, Kyungki-Do, Korea). Surgical prepara-
tion of neonatal piglets was initiated by sedation with keta-
mine (20 mg/kg, IM) and xylazine (2 mg/kg, IM), followed
by thiopental anesthesia (5 mg/kg, IV). After local injection
with lidocaine (1%) a tracheostomy was performed, and the
piglet was paralyzed with pancuronium (0.1 mg/kg, IV) fol-
lowed by hourly intravenous injections. Sedation was main-
tained with hourly doses of thiopental. The paralyzed piglet
was placed on a mechanical ventilator (Sechrist Infant Ven-
tilator, IV-100V) to attain an arterial O2 tension of 80-100
mmHg and an arterial CO2 tension of 35-45 mmHg. The
right femoral artery was cannulated for arterial blood gas sam-
pling and systemic arterial blood pressure monitoring. An in-
fusion of 0.9% saline containing 1U of heparin/mL was pro-
vided at a rate of 1-2 mL/hr through the arterial catheter that
were attached to a blood pressure transducer (Hewlett Packard
Model M1276A). A Hewlett Packard neonatal monitoring
system (M1276A) continuously monitored electrocardiogram,
oxygen saturation, and system arterial and pulmonary arterial
pressure. Animals were maintained supine with the head of
the bed elevated at 20 degrees upward throughout the study.
Constant body temperature was maintained at between 38-
39℃ by using a warmed operating table and servo-controlled
overhead heater.
Perfluorodecalin
Perfluorodecalin, a kind of PFC, is insoluble in water and
is too stable in room temperature to react when exposed to air
or water. The density of perfluorodecalin is 1.95 g/mL at 25℃,
kinematic viscosity is 2.90 centistoks at 25℃, boiling point
is 142℃, vapor pressure is 14 mmHg at 37℃, surface tension
is 15 dyne/cm at 25℃, oxygen solubility is 49 mL gas/100 mL
liquid at 25℃, and 140 mL gas/100 mL liquid.
Experimental Protocols
After a period of stabilization at about 30 min after anesthet-
ic and surgical procedures, the ventilator settings were adjusted
as follows: FiO2 1.0, rate 25/min, PIP 30 cmH2O, PEEP 4
cmH2O, and iT 0.7 sec. The newly adjusted settings were
maintained for 10 min. At this point, baseline measurements
of arterial blood gases, hemodynamic parameters were done.
Thereafter, induction of acute lung injury was done by repet-
itive lung lavage with warm saline. A dose of 30 mL/kg of
37℃ saline was instilled into trachea and was removed
repeatedly 4-6 times until an arterial O2 tension of 60 mmHg
was reached at a ventilator setting of FiO2 1.0, Fr 25/min, PIP
30 cmH2O, PEEP 4 cmH2O, and iT 0.7 sec. Lavage baseline
point (lavage), when stabilization was reached, was appointed
as about 30 min after lung lavage. Measurement of arterial
blood gases and hemodynamic parameters were done again
at this lavage baseline point. Then the newborn piglets were
randomly divided into two groups: HFOV only group (n=3)
and PLV with perfluorocarbon plus HFOV group (PFC+
HFOV group, n=4). HFOV (SensorMedics 3100A, Sesor-
Medics Critical Care, Yorba Linda, CA, U.S.A.) was applied
to the newborn piglets in HFOV only group at a setting of
FiO2 1.0, iT 33%, MAP 15 cmH2O, delta P 35-40 cmH2O,
and Fr 15 Hz. Newborn piglets in PFC+HFOV group receiv-
ed both perfluorodecalin and HFOV. Thirty min after HFOV
was applied, two consecutive doses of 37℃, 15 mL/kg of per-
fluorodecalin were administered slowly at a 30-min interval
through the side-port of an adapter that connects ventilator
circuit with endotracheal tube for 5 min. During the 5 min
for administration of perfluorodecalin, HFOV was replaced
with conventional ventilation at the same settings as baseline.
And then HFOV was applied at an altered setting, FiO2 1.0,
iT 50%, MAP 15 cmH2O, delta P 35-40 cmH2O, and Fr 10
Hz. Prolonged iT and decreasing frequency were necessary
to obtain adequate chest vibration of piglets, which was tes-
tified in our previous pilot study. All newborn piglets in each
group were maintained for three hours and were monitored
for arterial blood gases, hemodynamic parameters, and oxygena-
tion index at 30 min after the beginning of HFOV (HFOV),
at 30 min after each perfluorocarbon dosing (30’/ PFC1, 60’/
PFC2), and at 180 min after the first perfluorocarbon dos-
ing (180’).
Monitoring of Arterial Blood Gases, Hemodynamic
Parameters and Oxygenation Index
Heart rate and systemic arterial pressure (SAP) were mea-
sured through neonatal monitor (Hewlett-Packard Model
M1276A) by using femoral arterial catheters. Arterial blood
pH, O2 tension, and CO2 tension were measured from arterial
blood samples taken from the femoral arterial catheter. Blood
gases were analyzed by using Ciba-Corning blood gas analyz-
er. Oxygenation index was calculated as follows: OI=[MAP
(cmH2O)×FiO2]/[7.5×PaO2 (kPa)]
Data Analysis and Statistics
All numerical values measured were described as mean±
standard deviation. Arterial blood gases, hemodynamic para-
meters, and oxygenation indices were assessed by repeated
measures analysis of variance with the group as the main effect,
and time as the within-subject factor for the analysis of group-
by-time interaction and intragroup differences, taking the
Bonferroni principles into account. Intergroup difference at
each time point was evaluated by one-way analysis of variance.
We used SPSS (version 10.0) and StatView (version 5.0) for
these analyses. p-value lower than 0.05 was regarded significant.
RESULTS
At a baseline time point, there were no significant differencesin heart rates, mean arterial blood pressures, arterial blood pH
and gas tensions, and oxygenation indices between HFOV-only
group and PFC+HFOV group.
Repetitive lung lavage produced a significant decrease in
arterial blood pH (p<0.0001) and PaO2 (p<0.0001), and an
increase in PaCO2 (p<0.0001), mean arterial blood pressure
(p<0.0001) and oxygenation index (p<0.0001) in both the
HFOV-only group and PFC+HFOV group. After all, acute
respiratory failure manifested by marked acidemia, hypox-
emia, and hypercapnia was induced to newborn piglets in each
group, but there were no significant inter-group differences
in heart rates, mean arterial blood pressures, arterial blood pH
and gas tensions, and oxygenation indices (Table 1).
After HFOV was applied to newborn piglets in each group,
arterial blood pH (p=0.002) and PaO2 (p=0.0003) were signif-
icantly increased, and PaCO2 (p<0.0001), mean arterial blood
pressure (p<0.0001) and oxygenation index (p=0.0002) were
significantly decreased in both groups of animals. There were
no significant differences between the groups in heart rates,
arterial blood pH and gas tensions, and oxygenation indices,
except in mean arterial blood pressure at this time point. Mean
arterial blood pressure of newborn piglets in PFC+HFOV
group was significantly lower than that of animals in HFOV-
only group (54.2±5.1 vs. 86.6±23.1, p=0.03) (Fig. 1, 2).
Gas Exchange
Newborn piglets in HFOV-only group which were given
only HFOV did not produce further significant alterations in
arterial blood pH and gas tensions, and in oxygenation indices
to the end point of experiment, since they altogether showed
marked improvements in their gas exchange as soon as HFOV
was applied. The gas exchange of the animals in PFC+HFOV
group which were given both perfluorodecalin and HFOV
showed gradual improvements as two consecutive doses of
perfluorodecalin were administered, but the changes were not
significant as the results from HFOV-only group were not.
The fact that there were no significant differences in gas ex-
change pattern over time between the groups indicated that
PFC did not produce an additive effect on gas exchange of the
injured lung when added to HFOV. From the first perfluorode-
calin dosing to the end point of experiment (Fig. 1), there were
no significant differences in arterial pH, gas tensions, and oxy-
genation indices between the groups.
High-Frequency Oscillatory Ventilation and Partial Liquid Ventilation 665
Fig. 1. Plots representing gas exchange: Top left, arterial blood pH; top right, PaO2; bottom left, PaCO2; bottom right, oxygenation index at
baseline (base), after lavage (lavage), after the application of high-frequency oscillatory ventilation (HFOV), 30 min after each of two consecutive
doses of 15 mL/kg of perfluorodecalin at a 30-min interval (30’/PFC1, 60’/PFC2), and 180 min after the initiation of perfluorodecalin administration
(180’). HFOV, High-frequency oscillatory ventilation; PFC, Perfluorocarbon; *, p<0.05 compared to previous level within the group.
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Heart rate (/min) 169±21 215±34 183±37 196±77
Arterial blood  86±9 115±16* 66±11 103±14*
pressure (mmHg)
Arterial blood pH 7.64±0.06 7.23±0.14* 7.57±0.06 7.20±0.06*
PaO2 (mmHg) 474.1±61.4 32.9±8.9* 483.3±38.7 38.7±10.9*
PaCO2 (mmHg) 19.4±6.2 53.8±17.6* 21.6±3.6 56.7±13.9*
Oxygenation index 1.6±0.1 28.3±7.3* 1.6±0.2 21.4±4.9*
Table 1. Hemodynamic parameters and arterial blood gases
before and after lung lavage in two groups of newborn piglets
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Hemodynamic Parameters
Heart rates showed no significant changes over time in both
groups of animals and no intergroup differences throughout
the experiment as well. Mean arterial blood pressure did not
show a significant alteration since the first perfluorodecalin
dosing. In the intergroup comparison, mean arterial pressure
of newborn piglets in PFC+HFOV group was significantly
lower (57.7±11.6 vs. 87.0±9.8, p=0.01) than that of ani-
mals in HFOV-only group just after the first perfluorodecalin
dosing, but thereafter, there were no more intergroup differ-
ences to the end point of experiment. The results showed that
the addition of PFC to HFOV in the rescue treatment of in-
jured lung did not bring out a significant hemodynamic im-
pairment (Fig. 2).
DISCUSSION
Our results showed no significant alteration in hemodynam-
ic parameters by the administration of perfluorocarbon. Our
results illustrate that the combination of PLV and HFOV was
well tolerated in terms of hemodynamics. However, we did
not demonstrate a significant improvement in gas exchange
when perfluorocarbon was added to HFOV.
There have been several investigations that demonstrated
the additive effect of the combination of HFOV and perfluo-
rocarbon administration on gas exchange (7, 18-20). Baden
et al. (7) reported in their piglet model of saline lavage-induced
acute lung injury that low-dose (3 mL/kg) perflubron signif-
icantly increased arterial oxygen tension, compared with ani-
mals treated with HFOV alone, although additional doses of
perflubron beyond the original dose of 3 mL/kg failed to de-
monstrate significant improvements in oxygenation. They
supposed that oxygenation is maximized with only small doses
of perflubron in a HFOV setting, and that the increased doses
of perflubron are not necessary to further recruit alveoli. How-
ever, the absence of attempts to optimize lung volume by mod-
ification of HFOV settings according to each successive dose
of perflubron makes their results complicated to interpret.
Sukumar et al. (18) also demonstrated that the combination
of HFOV and perflubron administration significantly improv-
ed gas exchange and hemodynamic variables in preterm lambs
with respiratory distress syndrome, compared with animals
managed with HFOV alone. However, although HFOV set-
tings were adjusted to achieve optimal gas exchange in both
groups of animals, the optimization of gas exchange in HFOV
only group was not accomplished over a 5-hr of experiment.
The control animals receiving HFOV alone showed continued
hypoxia, hypercarbia, and acidosis throughout the study. In
the present study, we modified settings as to increase inspi-
ratory time to 50% from 33% and to decrease frequency to
10 Hz from 15 Hz during HFOV, in order to achieve adequate
chest vibration in anesthetized piglets immediately after the
instillation of perfluorodecalin. We assumed that this might
have optimized lung volume at each consecutive dose of 15
mL/kg of perfluorodecalin in our protocol. Actually, the param-
eters of gas exchange have already recovered to near their pre-
injury levels by HFOV alone in our study. This difference in
the extent of optimization of gas exchange in HFOV might
have led to such a disparity in outcomes. The optimization of
lung volume may be important for the proper evaluation of
the additive effect of PLV on gas exchange over HFOV alone.
However, there is also a possibility that there may be no room
for further improvement by addition of PLV, if the injured
lung has already recovered fully by HFOV alone. This may be
the case in our present study, because the parameters of gas ex-
change have already recovered to near its pre-injury level by
HFOV alone, as mentioned above. This might have influenced
on the negative result of our study. The present study was our
first study to evaluate the combined effect of HFOV and PLV.
In the next step, it may be needed to set a lung injury model
that is not recovered fully by HFOV alone, therefore enables
us to evaluate, if any synergistic effect of additional PLV.
There have been also several negative studies regarding the
combined effect of HFOV and PLV as well as our present
study. Investigation of Gothberg et al. with a preterm lamb
model of respiratory distress syndrome supports our results,
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in which there were no significant differences in arterial oxygen
tension or oxygenation index between HFOV and HFOV+
PLV group (19). The results of Doctor et al.’s experiment with
a swine model of lavage-induced acute lung injury is also sim-
ilar to ours, in that they did not demonstrate a significant im-
provement in oxygenation when perflubron was added to
HFOV (20). They suggested that there might be a region that,
while recruited by perfluorocarbon, is still a source of intrapul-
monary shunting, despite the tendency to perflubron to redis-
tribute blood flow to nondependent lung. However, they pro-
posed a possibility that the dose of perflubron they chose
might not be optimal to achieve the most efficient gas ex-
change during the use of HFOV. The dose of perflubron was
based on considerable experience with perflubron and conven-
tional mechanical ventilation in larger animals. This is also
the case in our study. We employed the dose of perfluorode-
calin that was used in our previous study (21). In that study,
perfluorodecalin was introduced in a conventional ventilation
setting, and showed a dose-response relationship with respect
to gas exchange. Therefore, the dose of perfluorodecalin used
in that study might have not produced optimal results in our
present study where HFOV was used. Doctor et al. (22) recent-
ly conducted an investigation to examine dose-response rela-
tionships regarding the efficiency of gas exchange and hemo-
dynamic function during the combination of HFOV and PLV
with an adult pig model of saline lavage-induced acute lung
injury. In that investigation, there was optimal dose of perflu-
bron (between 5 and 15 mL/kg) that enabled them to achieve
the lowest oxygenation index during the combination of
HFOV and PLV with perflubron. It thus appears that the fur-
ther experiment concerning dose-response relationship to seek
the optimal dose of perfluorodecalin in a HFOV setting de-
serves to be carried out.
There are reports of more favorable histopathologic outcome
in case of the combination of HFOV and PLV (18, 20), al-
though there is also a report of negative study (19). In our
present study, the histopathologic data of the animals were
not included, and this may be the shortcoming of our study. 
In our newborn piglets with saline lavage-induced acute
respiratory failure, we concluded that the addition of PLV with
30 mL/kg of perfluorodecalin to HFOV showed no detrimen-
tal effect on hemodynamic parameters, but did not produce
significant improvement in gas exchange over a three-hour
period, compared to HFOV alone.
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